These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15074077)

  • 1. Hormonal and genetic determinants of bone loss in community-dwelling elderly men: a longitudinal population study.
    Goemaere S; van Pottelbergh I; Kaufman JM
    Verh K Acad Geneeskd Belg; 2004; 66(2):81-95. PubMed ID: 15074077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.
    Van Pottelbergh I; Goemaere S; Kaufman JM
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3075-81. PubMed ID: 12843146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism.
    Gennari L; Masi L; Merlotti D; Picariello L; Falchetti A; Tanini A; Mavilia C; Del Monte F; Gonnelli S; Lucani B; Gennari C; Brandi ML
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2803-10. PubMed ID: 15181061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women.
    Dick IM; Devine A; Prince RL
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E989-95. PubMed ID: 15613678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density.
    Riancho JA; Zarrabeitia MT; Valero C; Sañudo C; Hernández JL; Amado JA; Zarrabeitia A; González-Macías J
    Bone; 2005 May; 36(5):917-25. PubMed ID: 15794932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length versus hormonal and bone mineral status in healthy elderly men.
    Bekaert S; Van Pottelbergh I; De Meyer T; Zmierczak H; Kaufman JM; Van Oostveldt P; Goemaere S
    Mech Ageing Dev; 2005 Oct; 126(10):1115-22. PubMed ID: 15967485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low calcaneal bone mineral density and the risk of distal forearm fracture in women and men: a population-based case-control study.
    Atroshi I; Ahlander F; Billsten M; Ahlborg HG; Mellström D; Ohlsson C; Ljunggren O; Karlsson MK
    Bone; 2009 Oct; 45(4):789-93. PubMed ID: 19539795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study.
    Lorentzon M; Swanson C; Eriksson AL; Mellström D; Ohlsson C
    J Bone Miner Res; 2006 Feb; 21(2):332-9. PubMed ID: 16418790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study.
    Meier C; Nguyen TV; Handelsman DJ; Schindler C; Kushnir MM; Rockwood AL; Meikle AW; Center JR; Eisman JA; Seibel MJ
    Arch Intern Med; 2008 Jan; 168(1):47-54. PubMed ID: 18195195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related influence of common aromatase gene polymorphisms on bone mass of healthy men.
    Zarrabeitia A; Zarrabeitia MT; Valero C; González-Macías J; Riancho JA
    Bone; 2004 Jul; 35(1):243-8. PubMed ID: 15207764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men--results from the Odense Androgen Study.
    Abrahamsen B; Jørgensen HL; Nielsen TL; Andersen M; Haug E; Schwarz P; Hagen C; Brixen K
    Bone; 2006 Feb; 38(2):215-9. PubMed ID: 16169307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifiable predictors of bone loss in older men: a prospective study.
    Bakhireva LN; Barrett-Connor E; Kritz-Silverstein D; Morton DJ
    Am J Prev Med; 2004 Jun; 26(5):436-42. PubMed ID: 15165661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.
    Lanfranco F; Zirilli L; Baldi M; Pignatti E; Corneli G; Ghigo E; Aimaretti G; Carani C; Rochira V
    Bone; 2008 Sep; 43(3):628-35. PubMed ID: 18590994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.
    Roberts RO; Bergstralh EJ; Farmer SA; Jacobson DJ; Hebbring SJ; Cunningham JM; Thibodeau SN; Lieber MM; Jacobsen SJ
    Prostate; 2006 Mar; 66(4):392-404. PubMed ID: 16302261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor beta dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women.
    Scariano JK; Simplicio SG; Montoya GD; Garry PJ; Baumgartner RN
    Calcif Tissue Int; 2004 Jun; 74(6):501-8. PubMed ID: 15354857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the CYP19 gene that influence bone mineral density.
    Riancho JA
    Pharmacogenomics; 2007 Apr; 8(4):339-52. PubMed ID: 17391072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of low bone mineral density in the elderly: the role of dietary intake, nutritional status and sarcopenia.
    Coin A; Perissinotto E; Enzi G; Zamboni M; Inelmen EM; Frigo AC; Manzato E; Busetto L; Buja A; Sergi G
    Eur J Clin Nutr; 2008 Jun; 62(6):802-9. PubMed ID: 17637603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of genetic lactase non-persistence and sex with bone loss in young adulthood.
    Laaksonen MM; Impivaara O; Sievänen H; Viikari JS; Lehtimäki TJ; Lamberg-Allardt CJ; Kärkkäinen MU; Välimäki M; Heikkinen J; Kröger LM; Kröger HP; Jurvelin JS; Kähönen MA; Raitakari OT;
    Bone; 2009 May; 44(5):1003-9. PubMed ID: 19168163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased peak bone mass is associated with a 3-bp deletion/insertion of the CYP19 intron 4 polymorphism: preliminary data from the GOOS study.
    Kastelan D; Grubic Z; Kraljevic I; Duric K; Kardum I; Dusek T; Stingl K; Giljevic Z; Kerhin-Brkljacic V; Suchanek E; Korsic M
    J Endocrinol Invest; 2007 Jun; 30(6):465-9. PubMed ID: 17646720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.